Before the RSV vaccines were approved, the FDA flagged potential GBS risks with the vaccines. After approval, the CDC ...

Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.

GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...

GBS most commonly affects the peripheral nervous ... the concentration of cerebrospinal fluid proteins. Understanding the causes of these mental-status changes should help to reassure doctors ...

The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...

GBS causes inflammation of the nerves and can lead to numbness, weakness and pain, usually in the feet, hands and limbs and can spread to the chest and face. It can be treated and most people will ...

Guillain-Barré Syndrome (GBS) is a disorder of the nervous system that affects the immune system, causes muscle weakness and paralysis, attacks the respiratory system, and may lead to the patient ...

The charity Group B Strep Support has said that GBS was the most common cause of life-threatening infections in newborns. Screening has not been recommended by the UK National Screening Committee.